Author:
Jinno Hideto,Tanaka-Kagawa Toshiko,Hanioka Nobumitsu,Saeki Mayumi,Ishida Seiichi,Nishimura Tetsuji,Ando Masanori,Saito Yoshiro,Ozawa Shogo,Sawada Jun-ichi
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmaceutical Science,Pharmacology
Reference27 articles.
1. In vitro activation of irinotecan to SN-38 by human liver and intestine.;Ahmed;Anticancer Res,1999
2. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.;Akaba;Biochem Mol Biol Int,1998
3. Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese
4. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.;Ando;Cancer Res,2000
5. UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献